[Biopharmaceutical, pharmacokinetic and pharmacodynamic aspects of glibenclamide compounds]. 1983

H Möller, and S L Ali, and U Gundert-Remy

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005905 Glyburide An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide Glibenclamide,Daonil,Diabeta,Euglucon 5,Euglucon N,Glybenclamide,HB-419,HB-420,Maninil,Micronase,Neogluconin,HB 419,HB 420,HB419,HB420
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

H Möller, and S L Ali, and U Gundert-Remy
June 2004, Journal of pharmaceutical sciences,
H Möller, and S L Ali, and U Gundert-Remy
October 2018, AAPS PharmSciTech,
H Möller, and S L Ali, and U Gundert-Remy
September 1973, Diabetologia,
H Möller, and S L Ali, and U Gundert-Remy
June 1990, British journal of clinical pharmacology,
H Möller, and S L Ali, and U Gundert-Remy
January 1992, Oncology research,
H Möller, and S L Ali, and U Gundert-Remy
December 1998, International journal of clinical pharmacology and therapeutics,
H Möller, and S L Ali, and U Gundert-Remy
January 1984, Annales chirurgiae et gynaecologiae,
H Möller, and S L Ali, and U Gundert-Remy
April 2014, Medizinische Klinik, Intensivmedizin und Notfallmedizin,
H Möller, and S L Ali, and U Gundert-Remy
June 2004, International journal of pharmaceutics,
H Möller, and S L Ali, and U Gundert-Remy
August 1985, Gerodontics,
Copied contents to your clipboard!